S. Mattox

发表

Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants.

B. Barlogie, S. Jagannath, D. Siegel, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

and not with other karyotype abnormalities 11q complete deletions of chromosome 13 or abnormalities involving Poor prognosis in multiple myeloma is associated only with partial or

B. Barlogie, S. Jagannath, G. Tricot, 2011 .

Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.

B. Barlogie, S. Jagannath, D. Siegel, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up after high-dose therapy for high-risk multiple myeloma

B. Barlogie, S. Jagannath, G. Tricot, 1998, Bone Marrow Transplantation.

Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?

B. Barlogie, S. Jagannath, S. Singhal, 1998, Bone Marrow Transplantation.

Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience

B. Barlogie, S. Jagannath, D. Siegel, 2003, British journal of haematology.

Translating Psychosocial Research Findings Into Practice Guidelines

P. Hinds, J. Gattuso, B. Powell, 2003, The Journal of nursing administration.

Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin.

B. Barlogie, S. Jagannath, G. Tricot, 1998, Blood.

Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities.

B. Barlogie, S. Jagannath, G. Tricot, 1995, Blood.

Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.

B. Barlogie, B. Cheson, S. Jagannath, 1997, Blood.

Total therapy with tandem transplants for newly diagnosed multiple myeloma.

B. Barlogie, B. Cheson, S. Jagannath, 1999, Blood.

Symptom Management and Successful Outpatient Transplantation for Patients With Multiple Myeloma

E. Coleman, P. O’Sullivan, S. Coon, 2002, Cancer nursing.

The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma

Pingping Qu, Bart Barlogie, Antje Hoering, 2017, Haematologica.

for Previously Untreated Multiple Myeloma Superiority of Tandem Autologous Transplantation Over Standard Therapy

B. Barlogie, B. Cheson, S. Jagannath, 2013 .